SCHEMBL7186444

SCHEMBL7186444

NNS(=O)(=O)c1ccccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.45
CA1 P00915 6/20 0.45
CA9 Q16790 5/20 0.45
CA6 P23280 3/20 0.45
CA5A P35218 3/20 0.45
CA12 O43570 3/20 0.45
CA7 P43166 2/20 0.45
CA5B Q9Y2D0 2/20 0.45
ACLY P53396 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CDK2 P24941 1/20 0.44
ACHE P22303 1/20 0.42
CA4 P22748 2/20 0.40
CYP2C9 P11712 1/20 0.40
CA14 Q9ULX7 1/20 0.40
LDHA P00338 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1427884 0.84 CA1 (0.48) CA2CA1CA9CA6CA5A
SCHEMBL7195481 0.80 CA2 (0.57) CA2CA1CA5ACA12CA5B
SCHEMBL32664392 0.78 CYP1A2 (0.51) ACLYMEN1KMT2ATDP1CDK2
SCHEMBL6657858 0.78 ACLY (0.44) CA2CA1CA9CA6CA5A
SCHEMBL8877154 0.78 MEN1 (0.44) CA2CA1CA9CA5AACLY
Phenolsulphonic Acid SCHEMBL16045143 0.77 AURKA (0.47) CA2CA1CA9CA6CA5A
SCHEMBL29965023 0.77 CDK2 (0.61) CA2CA1CA9CA6CA5A
SCHEMBL184251 0.77 CDK2 (0.61) CA2CA1CA9CA6CA5A
SCHEMBL6262661 0.76 GAA (0.60) CA2CA1CA9CA6CA5A
SCHEMBL8942179 0.75 IL1RN (0.55) CA2CA1CA9CA12ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11930811-B2 Antiviral vinyl-chloride resin composition, antiviral sheet of vinyl-chloride resin, process for producing the same, interior decorative sheet, process for producing interior decorative sheet, interior decorative sheet of poly (vinyl chloride) resin, antiviral wallpaper, and process for producing antiviral wallpaper LONSEAL CORPORATION (JP) 2024-03-19 US disclosed
EP-3020761-B1 ANTIVIRAL VINYL CHLORIDE RESIN COMPOSITION, ANTIVIRAL VINYL CHLORIDE RESIN SHEET, AND METHOD FOR MANUFACTURING SAME, INTERIOR SHEET, METHOD FOR MANUFACTURING INTERIOR SHEET, POLYVINYL CHLORIDE RESIN INTERIOR SHEET, ANTIVIRAL WALLPAPER, AND METHOD FOR MANUFACTURING ANTIVIRAL WALLPAPER LONSEAL KOGYO KK (JP) 2021-12-22 EP disclosed
US-20210179834-A1 ANTIVIRAL VINYL-CHLORIDE RESIN COMPOSITION, ANTIVIRAL SHEET OF VINYL-CHLORIDE RESIN, PROCESS FOR PRODUCING THE SAME, INTERIOR DECORATIVE SHEET, PROCESS FOR PRODUCING INTERIOR DECORATIVE SHEET, INTERIOR DECORATIVE SHEET OF POLY(VINYL CHLORIDE) RESIN, ANTIVIRAL WALLPAPER, AND PROCESS FOR PRODUCING ANTIVIRAL WALLPAPER LONSEAL KOGYO KK (JP) 2021-06-17 US disclosed
US-20180282534-A1 ANTIVIRAL VINYL-CHLORIDE RESIN COMPOSITION, ANTIVIRAL SHEET OF VINYL-CHLORIDE RESIN, PROCESS FOR PRODUCING THE SAME, INTERIOR DECORATIVE SHEET, PROCESS FOR PRODUCING INTERIOR DECORATIVE SHEET, INTERIOR DECORATIVE SHEET OF POLY(VINYL CHLORIDE) RESIN, ANTIVIRAL WALLPAPER, AND PROCESS FOR PRODUCING ANTIVIRAL WALLPAPER LONSEAL KOGYO KK (JP) 2018-10-04 US disclosed
US-10053570-B2 Antiviral vinyl-chloride resin composition, antiviral sheet of vinyl-chloride resin, process for producing the same, interior decorative sheet, process for producing interior decorative sheet, interior decorative sheet of poly(vinyl chloride) resin, antiviral wallpaper, and process for producing antiviral wallpaper LONSEAL CORPORATION (JP) 2018-08-21 US disclosed
US-20160143273-A1 ANTIVIRAL VINYL-CHLORIDE-BASED RESIN COMPOSITION, ANTIVIRAL SHEET OF VINYL-CHLORIDE-BASED RESIN, PROCESS FOR PRODUCING THE SAME, INTERIOR DECORATIVE SHEET, PROCESS FOR PRODUCING INTERIOR DECORATIVE SHEET, INTERIOR DECORATIVE SHEET OF POLY(VINYL CHLORIDE)-BASED RESIN, ANTIVIRAL WALLPAPER, AND PROCESS FOR PRODUCING ANTIVIRAL WALLPAPER LONSEAL CORPORATION (JP) 2016-05-26 US disclosed
EP-3020761-A1 ANTIVIRAL VINYL CHLORIDE RESIN COMPOSITION, ANTIVIRAL VINYL CHLORIDE RESIN SHEET, AND METHOD FOR MANUFACTURING SAME, INTERIOR SHEET, METHOD FOR MANUFACTURING INTERIOR SHEET, POLYVINYL CHLORIDE RESIN INTERIOR SHEET, ANTIVIRAL WALLPAPER, AND METHOD FOR MANUFACTURING ANTIVIRAL WALLPAPER Lonseal Corporation (JP) 2016-05-18 EP disclosed
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CA2 1428/4885CA1 1889/4885CA9 2894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.